News
Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease Provided by Business Wire Jul 29, 2025, 1:12:00 AM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback